B Cell News and Research

RSS

Study reveals biological basis of severe neurological disorder in children

In a new study published today in The American Journal of Human Genetics, a multinational team of researchers describes, for the first time, the biological basis of a severe neurological disorder in children.

3 Aug 2017

Study findings could lead to more effective and faster acting antidepressants

For people suffering from depression, a day without treatment can seem like a lifetime. A new study explains why the most commonly prescribed antidepressants can take as long as six weeks to have an effect. The findings could one day lead to more effective and faster acting drugs.

3 Aug 2017

Scientists propose therapeutic strategy to suppress formation of hereditary bony tumors

Patients with multiple hereditary exostoses (MHE)--a rare disease that causes the growth of multiple benign bone tumors -- have limited treatment options.

3 Aug 2017

MIT engineers devise noninvasive way to assess cell's mechanical properties

The stiffness or elasticity of a cell can reveal much about whether the cell is healthy or diseased. Cancer cells, for instance, are known to be softer than normal, while asthma-affected cells can be rather stiff.

3 Aug 2017

Researchers develop potential stem cell treatment for several lung conditions

A team of scientists from the UNC School of Medicine and North Carolina State University has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis -- often-fatal conditions that affect tens of millions of Americans.

3 Aug 2017

Sheffield scientists discover that simple arthritis drug could help treat blood cancer sufferers

Blood cancer sufferers could be treated with a simple arthritis drug, scientists at the University of Sheffield have discovered.

3 Aug 2017

Botulinum neurotoxin type X holds potential to open up new field of toxin therapeutics

Botulinum toxins are currently used on more than 80 medical conditions including Muscle spasms, Overactive bladder, Chronic migraine, Cervical dystonia, Sweating and Cerebral Palsy (CP).

3 Aug 2017

Biologic substance APOSEC shows promise for healing dermal wounds

APOSEC is a substance obtained from white blood corpuscles and was developed by a research group led by thoracic surgeon Hendrik Jan Ankersmit, Head of the Christian Doppler Laboratory for Cardiac and Thoracic Diagnosis and Regeneration at MedUni Vienna.

3 Aug 2017

When wounds won’t heal, therapies spread — to the tune of $5 billion

Carol Emanuele beat cancer. But for the past two years, she has been fighting her toughest battle yet. She has an open wound on the bottom of her foot that leaves her unable to walk and prone to deadly infection.

3 Aug 2017

IDT introduces first Cas9 enzyme variant that greatly reduces off-target effects in CRISPR genome editing

Integrated DNA Technologies today announced the launch of the first Cas9 enzyme variant that extensively reduces off-target effects in CRISPR genome editing without compromising on-target activity.

3 Aug 2017

BioTek launches next-generation 800 TS microplate reader and 50 TS washer

BioTek announces the launch of its new microplate reader and washer duo, the 800 TS and 50 TS.

3 Aug 2017

Study shows new method for repairing disease-causing mutation in human embryos

Scientists have demonstrated an effective way of using a gene-editing tool to correct a disease-causing gene mutation in human embryos and stop it from passing to future generations.

3 Aug 2017

Researchers deliver knock-out blow to different types of cancer

Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease, according to research funded by Cancer Research UK and published in the Journal of the National Cancer Institute today (Thursday).

3 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

Researchers ferreting out patients most likely to become resistant to cancer treatment

According to the National Cancer Institute, the number of people beating a cancer diagnosis reached nearly 14.5 million in 2014 and is expected to rise to almost 19 million by 2024. Now, that's good news, but it doesn't mean that cancer researchers - in the lab or clinic - are resting on any laurels.

2 Aug 2017

B Cell News and Research

Study reveals biological basis of severe neurological disorder in children

Study findings could lead to more effective and faster acting antidepressants

Scientists propose therapeutic strategy to suppress formation of hereditary bony tumors

MIT engineers devise noninvasive way to assess cell's mechanical properties

Researchers develop potential stem cell treatment for several lung conditions

Sheffield scientists discover that simple arthritis drug could help treat blood cancer sufferers

Botulinum neurotoxin type X holds potential to open up new field of toxin therapeutics

Biologic substance APOSEC shows promise for healing dermal wounds

When wounds won’t heal, therapies spread — to the tune of $5 billion

IDT introduces first Cas9 enzyme variant that greatly reduces off-target effects in CRISPR genome editing

BioTek launches next-generation 800 TS microplate reader and 50 TS washer

Study shows new method for repairing disease-causing mutation in human embryos

Researchers deliver knock-out blow to different types of cancer

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Researchers ferreting out patients most likely to become resistant to cancer treatment

Anti-allergy medicines may be effective treatment for deadly blood clots in the legs

Scientists reveal new method to reprogram specific T cells

Stowers researchers solve 3D structure of critical protein complex using microscopy techniques

Research shows great potential of embryonic gene editing to prevent inherited diseases

Vanderbilt researchers unravel how bacterial toxin prevents DNA replication

Immunology eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News